About

Acceptance Rate:
14%
Time to first decision with review:
17 days
Impact Factor (JCR):
5.558
Citescore:
5.5
Total content views:
953,413
2020 total Altmetric mentions:
27,509

Aims and scope

BMJ Global Health is an open access, online journal from BMJ dedicated to publishing high-quality peer-reviewed content relevant to those involved in global health, including policy makers, funders, researchers, clinicians and frontline healthcare workers. To find out more about the journal’s vision, please read the introductory editorial from the journal’s Editor-in-Chief, Dr Seye Abimbola. The journal covers all aspects of global health, with particular interest in submissions that address the underfunded area of non-communicable diseases (NCDs). Research across all study phases and designs is welcome, from study protocols to phase I trials to meta-analyses, including small or specialist studies. The editor welcomes opinionated discussions on controversial topics to stimulate debate.
BMJ Global Health adheres to BMJ’s rigorous standards of peer-review and papers are considered on the basis of ethical and methodological soundness rather than their novelty, significance, or relevance to any particular group. The journal operates a fast submission process with continuous publication online to ensure that timely, up-to-date research is available worldwide to those who need it.

Ownership

BMJ Global Health is owned by BMJ.

Editorial board

For information about the BMJ Global Health editorial team, please refer to the Editorial Board page.

Journal information

Publication Model
Open access
Frequency
Continuous online publication
Launch date
2016
Digital Archives
Indexed by
Science Citation Index Expanded (also known as SciSearch®); Journal Citation Reports/Science Edition and Social Sciences Edition; Social Sciences Citation Index®; Current Contents®/Social and Behavioral Sciences; MEDLINE; PubMed Central;  Scopus; DOAJ; Google Scholar
Peer review model
Single blind; the names of reviewers are hidden from the author
Online ISSN
2059-7908

Journal Statistics (2020)

Acceptance rate: 22%
Speed Days to first decision: 15 days (mean) Days from acceptance to publication: 17 days (mean)
Impact Impact Factor category: Public, Environmental & Occupational Health Impact Factor (JCR): 5.558 Impact Factor rank (JCR): 27/204 (SCIE), 10/176 (SSCI) 5 Year Impact Factor: 5.908 Journal Citation Indicator: 1.56 Eigenfactor: 0.01806 Citescore: 5.5 Citescore rank: 19/242 Scimago Journal Rank (SJR): 2.111
Reach 2020 total content views: 953,413 2020 total Altmetric mentions: 27,509
SFDORA logo
The impact that academic research has cannot be defined by one single metric. In 2013, BMJ signed the San Francisco Declaration on Research Assessment (DORA). We did this to show our support for using multiple measures and metrics to portray journals’ impact; moving away from the Impact Factor as a single measure. How we get these metrics

Affiliations

DRYAD logo
Dryad is an international repository of data underlying peer-reviewed articles in the basic and applied biosciences. Dryad enables scientists to validate published findings, explore new analysis methodologies, repurpose data for research questions unanticipated by the original authors, and perform synthetic studies. BMJ has been working with Dryad since 2010.
COPE logo
The BMJ is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.
CASPA logo
The mission of OASPA is to support and represent the interests of open access journal publishers globally in all scientific, technical, and scholarly disciplines. The BMJ Publishing Group has been a member since 2009.
Open Access articles in BMJ Global Health are licensed using either Creative Commons Attribution (CC BY) or Attribution Non-Commercial (CC BY-NC) license. These licenses let others distribute, remix, tweak and build upon your work.
AllTrials logo
BMJ is a founding organisation of the AllTrials initiative, which calls for all past and present clinical trials to be registered and their results reported.